HomeCLINICAL TRIALS, STUDIES, REGISTRIES, DATA
CLINICAL TRIALS, STUDIES, REGISTRIES, DATA
Clinical trials, studies, data, and updates reported in Medical Device News Magazine.
New Study Shows High Patient Satisfaction and Outcomes After Outpatient Joint Arthroplasty at Academic Medical Centers
The study, "Patient Satisfaction and Outcomes following Outpatient Joint Arthroplasty in Academic Medical Centers," presented at the 2023 American Academy of Orthopaedic Surgeons (AAOS) Annual Meeting, also showed that patients had short discharge times and low readmission rates after outpatient total joint arthroplasty.
New Study Demonstrates that Running Does Not Increase Risk of Arthritis
Dr. Hartwell and his colleagues conducted the prospective cohort study, "Does Running Increase the Risk for Hip and Knee Arthritis? A Survey of 3,804 Chicago Marathon Runners," during his residency at Northwestern University Feinberg School of Medicine in Chicago.
Total Hip Arthroplasty Patients Under 65 Have Low Revision Rates at Eight Years
In the study, "Trends in Complications and Outcomes in Patients Aged 65 and Younger Undergoing Total Hip Arthroplasty: Data from the American Joint Replacement Registry," the team used the Registry's database to identify all THA procedures performed from 2012 through 2020 in patients aged 18 to 65. Exclusion criteria included patients with revision and oncologic THA cases, conversion from prior surgery and non-elective cases. The study measured primary outcomes including cumulative revision rate, 90-day readmission rate and reason for revision. In total, 5,153 patients were included in the analysis (51% female and 49% male) with an average age of 56.7 years ± 7.8 years. Mean follow up was 39.57 months.
Research Published in JSES Indicates that the Catalyst™ CSR Total Shoulder System Outperforms Traditional Stemmed Implants
Catalyst anatomic CSR results in better range of motion and improved restoration of the radiographic center of rotation when compared to a standard stemmed total shoulder system.
New Study Evaluates the Use of Masimo PVi® As an Indicator of Fluid Responsiveness to Guide Goal-Directed Fluid Therapy in Adult Neurosurgical Patients
Joe Kiani, Founder and CEO of Masimo, said, “We introduced Masimo PVi® in 2007. It was the first and still is the only noninvasive way of measuring fluid responsiveness in mechanically ventilated patients at a fraction of the cost of invasive methods and without risk of invasive procedures to the patient.
Philips: Clinical Evidence Presented at ACC.23/WCC Highlights How Utilization of Philips Cardiology Solutions is Improving the Quality and Efficiency of Patient Care
Presentation of various clinical study results at this year’s Annual Scientific Session & Expo of the American College of Cardiology/World Congress of Cardiology event (ACC.23/WCC, March 4 – 6, New Orleans, USA) that confirm Philips’ commitment to clinically validating its innovations in cardiac and cardiovascular care.
New Study Demonstrates Inferior Vena Cava Filters Are Safe & Effective Way to Treat Venous Thromboembolism
Data show IVC filter use led to few adverse events, even when used prophylactically.
Brainomix Technology Integrated into New UK Atrial Fibrillation Study
Brainomix notes the study will assess the role of Huawei’s wearable technology to detect atrial fibrillation in post-stroke patients.
InspiraTM Technologies Receives Approval from Sheba Medical Center to Conduct Clinical Study of the HYLATM Blood Sensor
The HYLA blood sensor is a non-invasive optical blood sensor being developed using machine learning based algorithms to measure blood parameters, intended to provide continuous measurements in real-time during extracorporeal procedures.